Effect of transurethral electrovaporization of the prostate on serum prostate specific antigen concentration


Küpeli S., SOYGÜR Y. T., YILMAZ E., Aytaç S.

BJU International, cilt.83, sa.7, ss.783-785, 1999 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 83 Sayı: 7
  • Basım Tarihi: 1999
  • Doi Numarası: 10.1046/j.1464-410x.1999.00002.x
  • Dergi Adı: BJU International
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.783-785
  • Anahtar Kelimeler: Electrovaporization, Prostate specific antigen, Prostatic hyperplasia
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Objective. To assess the effect of transurethral electrovaporization of the prostate (TUVP) on serum prostate specific antigen (PSA) concentration. Patients and methods. Twenty-five men (mean age 61.7 years) with symptoms of prostatism underwent TUVP. Serum PSA levels were determined before any prostatic manipulation, and again at 1 and 24 h after TUVP. In the first 6 weeks after TUVP, serum PSA was measured every week. Prostatic size was measured by transrectal ultrasonography before and again at 6 weeks after TUVP. Results. The mean serum PSA concentration was significantly higher at 1 and 24 h after TUVP (P < 0.001) than before. The PSA level returned to less than the value before TUVP at 2, 3 and 4 weeks afterwards in eight (32%), 13 (52%) and 20 (80%) patients, respectively: five (20%) patients reached the baseline value 6 weeks after TUVP. The mean reduction in prostatic volume 6 weeks after TUVP was 42% and the reduction in tissue volume was significantly correlated with the decrease in serum PSA concentration at 6 weeks (P < 0.05). Conclusion. TUVP increases serum PSA levels, the transient elevation persisting for up to 6 weeks but then declining to a stable, low PSA concentration. Therefore, it is important to wait at least 6 weeks to obtain an accurate and meaningful serum PSA level after TUVP.